|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000120327 |
Summary for PCDHB14 |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000120327 | Gene symbol | PCDHB14 |
| Gene name | protocadherin beta 14 | |
| HGNC | 8685 | |
| Entrez ID | 56122 | |
| Gene type | protein_coding | |
| Synonyms | PCDHB14|PCDH-BETA14 | |
| UniProtAcc | Q9Y5E9 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for PCDHB14 |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor male and normal male samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| PCDHB14 | 5.13e+02 | 1.11e+00 | 2.27e-01 | 4.87e+00 | 1.10e-06 | 3.89e-06 | KIRP |
| PCDHB14 | 4.79e+02 | 2.29e+00 | 5.01e-01 | 4.56e+00 | 5.07e-06 | 3.08e-05 | CHOL |
| Differentially expressed gene analysis between tumor female and normal female samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| PCDHB14 | 5.71e+02 | 1.22e+00 | 2.94e-01 | 4.16e+00 | 3.19e-05 | 9.75e-05 | LUSC |
| PCDHB14 | 2.55e+02 | 1.12e+00 | 2.04e-01 | 5.50e+00 | 3.85e-08 | 1.64e-07 | COAD |
Top |
Sex-biased somatic mutation for PCDHB14 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for PCDHB14 |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| HNSC | cg21745283 | chr5:141222947 | CGI:chr5:141224881-141225732 | UTR,promoter,exon,gene body | 5.07e-01 | 6.10e-01 | 2.97e+00 | 2.95e-03 | 8.29e-03 | -1.03e-01 |
| BLCA | cg21745283 | chr5:141222947 | CGI:chr5:141224881-141225732 | UTR,promoter,exon,gene body | 5.15e-01 | 6.89e-01 | 5.28e+00 | 1.29e-07 | 1.07e-06 | -1.75e-01 |
| LIHC | cg21745283 | chr5:141222947 | CGI:chr5:141224881-141225732 | UTR,promoter,exon,gene body | 5.36e-01 | 3.25e-01 | 3.07e+00 | 2.16e-03 | 6.34e-03 | 2.12e-01 |
| ESCA | cg10043954 | chr5:141223462 | CGI:chr5:141224881-141225732 | UTR,promoter,exon,gene body | 2.55e-01 | 3.74e-01 | -2.27e+00 | 2.34e-02 | 4.04e-02 | -1.19e-01 |
| MESO | cg21522026 | chr5:141223387 | CGI:chr5:141224881-141225732 | UTR,promoter,exon,gene body | 2.10e-01 | 3.21e-01 | -2.45e+00 | 1.42e-02 | 3.37e-02 | -1.12e-01 |
| MESO | cg10043954 | chr5:141223462 | CGI:chr5:141224881-141225732 | UTR,promoter,exon,gene body | 2.49e-01 | 3.55e-01 | -2.26e+00 | 2.39e-02 | 4.11e-02 | -1.06e-01 |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| KIRC | cg12396306 | chr5:141223279 | CGI:chr5:141224881-141225732 | UTR,promoter,exon,gene body | 1.50e-01 | 4.46e-02 | 4.15e+00 | 3.26e-05 | 7.64e-05 | 1.05e-01 |
| KIRC | cg08536529 | chr5:141223317 | CGI:chr5:141224881-141225732 | UTR,promoter,exon,gene body | 2.09e-01 | 1.04e-01 | 2.59e+00 | 9.59e-03 | 1.15e-02 | 1.05e-01 |
| HNSC | cg10804974 | chr5:141223698 | CGI:chr5:141224881-141225732 | promoter,exon,CDS,gene body | 4.78e-01 | 5.80e-01 | -3.27e+00 | 1.08e-03 | 1.93e-03 | -1.02e-01 |
| LUSC | cg21745283 | chr5:141222947 | CGI:chr5:141224881-141225732 | UTR,promoter,exon,gene body | 6.66e-01 | 4.81e-01 | 2.57e+00 | 1.01e-02 | 1.40e-02 | 1.85e-01 |
| KIRP | cg21745283 | chr5:141222947 | CGI:chr5:141224881-141225732 | UTR,promoter,exon,gene body | 6.72e-01 | 5.65e-01 | 2.82e+00 | 4.86e-03 | 6.96e-03 | 1.07e-01 |
| CHOL | cg12396306 | chr5:141223279 | CGI:chr5:141224881-141225732 | UTR,promoter,exon,gene body | 4.03e-01 | 5.76e-02 | 2.51e+00 | 1.22e-02 | 2.39e-02 | 3.46e-01 |
| CHOL | cg21522026 | chr5:141223387 | CGI:chr5:141224881-141225732 | UTR,promoter,exon,gene body | 4.93e-01 | 1.95e-01 | 2.73e+00 | 6.38e-03 | 1.82e-02 | 2.98e-01 |
| CHOL | cg06327515 | chr5:141223689 | CGI:chr5:141224881-141225732 | promoter,exon,CDS,gene body | 4.68e-01 | 1.88e-01 | 2.73e+00 | 6.38e-03 | 1.82e-02 | 2.80e-01 |
| CHOL | cg10804974 | chr5:141223698 | CGI:chr5:141224881-141225732 | promoter,exon,CDS,gene body | 6.19e-01 | 3.76e-01 | 2.06e+00 | 3.90e-02 | 4.26e-02 | 2.43e-01 |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg12396306 | chr5:141223279 | CGI:chr5:141224881-141225732 | UTR,promoter,exon,gene body | 1.83e-01 | 5.33e-02 | 5.33e+00 | 1.00e-07 | 2.05e-07 | 1.30e-01 |
| BRCA | cg21745283 | chr5:141222947 | CGI:chr5:141224881-141225732 | UTR,promoter,exon,gene body | 5.82e-01 | 4.54e-01 | 3.83e+00 | 1.27e-04 | 1.87e-04 | 1.28e-01 |
| BRCA | cg08536529 | chr5:141223317 | CGI:chr5:141224881-141225732 | UTR,promoter,exon,gene body | 2.49e-01 | 1.17e-01 | 3.16e+00 | 1.60e-03 | 2.05e-03 | 1.32e-01 |
| BRCA | cg21522026 | chr5:141223387 | CGI:chr5:141224881-141225732 | UTR,promoter,exon,gene body | 3.32e-01 | 2.14e-01 | 3.00e+00 | 2.66e-03 | 3.28e-03 | 1.18e-01 |
| LUAD | cg21522026 | chr5:141223387 | CGI:chr5:141224881-141225732 | UTR,promoter,exon,gene body | 3.67e-01 | 2.38e-01 | 2.28e+00 | 2.26e-02 | 2.82e-02 | 1.30e-01 |
| LUAD | cg06327515 | chr5:141223689 | CGI:chr5:141224881-141225732 | promoter,exon,CDS,gene body | 3.77e-01 | 2.56e-01 | 2.65e+00 | 8.00e-03 | 1.34e-02 | 1.22e-01 |
| LIHC | cg12396306 | chr5:141223279 | CGI:chr5:141224881-141225732 | UTR,promoter,exon,gene body | 1.45e-01 | 4.05e-02 | 3.63e+00 | 2.88e-04 | 8.62e-04 | 1.04e-01 |
| LIHC | cg21745283 | chr5:141222947 | CGI:chr5:141224881-141225732 | UTR,promoter,exon,gene body | 5.36e-01 | 3.35e-01 | 3.26e+00 | 1.11e-03 | 2.44e-03 | 2.01e-01 |
| LIHC | cg08536529 | chr5:141223317 | CGI:chr5:141224881-141225732 | UTR,promoter,exon,gene body | 1.95e-01 | 8.67e-02 | 2.63e+00 | 8.42e-03 | 1.21e-02 | 1.08e-01 |
| KIRP | cg12396306 | chr5:141223279 | CGI:chr5:141224881-141225732 | UTR,promoter,exon,gene body | 1.45e-01 | 4.49e-02 | 2.11e+00 | 3.53e-02 | 3.93e-02 | 1.00e-01 |
| KIRP | cg08536529 | chr5:141223317 | CGI:chr5:141224881-141225732 | UTR,promoter,exon,gene body | 2.06e-01 | 9.24e-02 | 2.14e+00 | 3.26e-02 | 3.72e-02 | 1.14e-01 |
Top |
Exon skipping events with PSI in TCGA for PCDHB14 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for PCDHB14 |
| ∗Please access CAeditome for RNA editing annotation. |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for PCDHB14 |
| TFs related to PCDHB14. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| BRCA | CTCFL | PCDHB14 | 4.94e+00 | 9.83e-01 | 3.78e+00 | 1.27e-02 | Male-biased |
| CHOL | FOXJ3 | PCDHB14 | 5.73e+00 | 7.84e-03 | 6.73e+00 | 9.92e-01 | Female-biased |
| CHOL | HOXC10 | PCDHB14 | 6.17e+00 | 1.02e-02 | 7.10e+00 | 9.89e-01 | Female-biased |
| CHOL | STAT2 | PCDHB14 | 4.74e+00 | 1.49e-02 | 5.58e+00 | 9.84e-01 | Female-biased |
| CHOL | ZNF418 | PCDHB14 | 5.12e+00 | 1.51e-03 | 6.53e+00 | 9.98e-01 | Female-biased |
| CHOL | ZNF716 | PCDHB14 | 5.69e+00 | 8.35e-03 | 6.68e+00 | 9.91e-01 | Female-biased |
| ESCA | RREB1 | PCDHB14 | 5.21e+00 | 9.86e-01 | 4.53e+00 | 1.24e-02 | Male-biased |
| ESCA | ZNF2 | PCDHB14 | 6.39e+00 | 9.89e-01 | 5.68e+00 | 1.08e-02 | Male-biased |
| ESCA | ZNF235 | PCDHB14 | 4.19e+00 | 8.37e-03 | 5.03e+00 | 9.89e-01 | Female-biased |
| ESCA | ZNF287 | PCDHB14 | 4.34e+00 | 1.63e-02 | 5.03e+00 | 9.81e-01 | Female-biased |
| GBM | CTCFL | PCDHB14 | 6.59e+00 | 9.99e-01 | 4.25e+00 | 1.44e-04 | Male-biased |
| GBM | RREB1 | PCDHB14 | 6.06e+00 | 9.98e-01 | 4.34e+00 | 1.51e-03 | Male-biased |
| GBM | ZNF2 | PCDHB14 | 6.87e+00 | 9.99e-01 | 4.93e+00 | 6.69e-04 | Male-biased |
| GBM | ZNF586 | PCDHB14 | 6.12e+00 | 9.86e-01 | 5.11e+00 | 1.36e-02 | Male-biased |
| GBM | ZNF823 | PCDHB14 | 5.84e+00 | 9.85e-01 | 4.85e+00 | 1.42e-02 | Male-biased |
| LAML | ZNF418 | PCDHB14 | 7.50e+00 | 9.82e-01 | 6.73e+00 | 1.78e-02 | Male-biased |
| LGG | ZNF418 | PCDHB14 | 5.22e+00 | 1.51e-02 | 5.65e+00 | 9.84e-01 | Female-biased |
| PAAD | CTCFL | PCDHB14 | 4.19e+00 | 1.37e-03 | 5.39e+00 | 9.97e-01 | Female-biased |
| PAAD | FOXJ3 | PCDHB14 | 6.28e+00 | 9.84e-01 | 5.53e+00 | 1.49e-02 | Male-biased |
| PAAD | HOXC10 | PCDHB14 | 6.66e+00 | 9.90e-01 | 5.81e+00 | 9.13e-03 | Male-biased |
| PAAD | RREB1 | PCDHB14 | 3.99e+00 | 1.34e-02 | 4.73e+00 | 9.82e-01 | Female-biased |
| PAAD | STAT2 | PCDHB14 | 5.47e+00 | 9.91e-01 | 4.57e+00 | 7.52e-03 | Male-biased |
| PAAD | ZNF2 | PCDHB14 | 4.78e+00 | 5.62e-03 | 5.71e+00 | 9.93e-01 | Female-biased |
| PAAD | ZNF418 | PCDHB14 | 6.39e+00 | 9.99e-01 | 4.96e+00 | 4.67e-04 | Male-biased |
| PAAD | ZNF716 | PCDHB14 | 6.34e+00 | 9.93e-01 | 5.42e+00 | 6.67e-03 | Male-biased |
| SARC | CTCFL | PCDHB14 | 5.06e+00 | 9.82e-01 | 4.56e+00 | 1.46e-02 | Male-biased |
| SARC | PRDM6 | PCDHB14 | 4.51e+00 | 6.38e-03 | 5.24e+00 | 9.92e-01 | Female-biased |
| SARC | ZNF2 | PCDHB14 | 6.23e+00 | 9.92e-01 | 5.63e+00 | 7.78e-03 | Male-biased |
| SARC | ZNF22 | PCDHB14 | 4.59e+00 | 6.59e-03 | 5.32e+00 | 9.92e-01 | Female-biased |
| SARC | ZNF225 | PCDHB14 | 4.99e+00 | 1.05e-02 | 5.63e+00 | 9.88e-01 | Female-biased |
| SARC | ZNF235 | PCDHB14 | 4.13e+00 | 2.55e-03 | 5.02e+00 | 9.95e-01 | Female-biased |
| SARC | ZNF287 | PCDHB14 | 4.29e+00 | 5.32e-03 | 5.05e+00 | 9.92e-01 | Female-biased |
| SARC | ZNF418 | PCDHB14 | 5.88e+00 | 3.77e-03 | 6.71e+00 | 9.96e-01 | Female-biased |
| SARC | ZNF487 | PCDHB14 | 4.56e+00 | 7.88e-03 | 5.25e+00 | 9.90e-01 | Female-biased |
| THYM | ZNF418 | PCDHB14 | 6.21e+00 | 7.72e-03 | 6.97e+00 | 9.92e-01 | Female-biased |
| UVM | CTCFL | PCDHB14 | 3.49e+00 | 8.50e-04 | 5.90e+00 | 9.98e-01 | Female-biased |
| UVM | FOXJ3 | PCDHB14 | 7.04e+00 | 9.99e-01 | 4.52e+00 | 6.48e-04 | Male-biased |
| UVM | GATA1 | PCDHB14 | 8.78e+00 | 9.90e-01 | 7.43e+00 | 9.90e-03 | Male-biased |
| UVM | HOXC10 | PCDHB14 | 7.38e+00 | 9.99e-01 | 4.87e+00 | 6.75e-04 | Male-biased |
| UVM | PRDM6 | PCDHB14 | 6.04e+00 | 9.98e-01 | 3.57e+00 | 7.35e-04 | Male-biased |
| UVM | RREB1 | PCDHB14 | 3.65e+00 | 2.92e-03 | 5.56e+00 | 9.94e-01 | Female-biased |
| UVM | STAT2 | PCDHB14 | 6.14e+00 | 9.99e-01 | 3.31e+00 | 2.59e-04 | Male-biased |
| UVM | ZNF2 | PCDHB14 | 4.65e+00 | 1.06e-02 | 5.94e+00 | 9.88e-01 | Female-biased |
| UVM | ZNF22 | PCDHB14 | 6.06e+00 | 9.98e-01 | 3.62e+00 | 7.91e-04 | Male-biased |
| UVM | ZNF225 | PCDHB14 | 6.28e+00 | 9.99e-01 | 3.47e+00 | 2.71e-04 | Male-biased |
| UVM | ZNF235 | PCDHB14 | 6.06e+00 | 9.98e-01 | 3.48e+00 | 5.29e-04 | Male-biased |
| UVM | ZNF280A | PCDHB14 | 7.25e+00 | 9.95e-01 | 5.57e+00 | 5.06e-03 | Male-biased |
| UVM | ZNF287 | PCDHB14 | 5.96e+00 | 9.98e-01 | 3.50e+00 | 7.48e-04 | Male-biased |
| UVM | ZNF418 | PCDHB14 | 7.37e+00 | 1.00e+00 | 2.55e+00 | 2.64e-06 | Male-biased |
| UVM | ZNF487 | PCDHB14 | 6.01e+00 | 9.98e-01 | 3.61e+00 | 8.84e-04 | Male-biased |
| UVM | ZNF492 | PCDHB14 | 6.06e+00 | 9.97e-01 | 3.86e+00 | 1.51e-03 | Male-biased |
| UVM | ZNF716 | PCDHB14 | 6.99e+00 | 9.98e-01 | 4.73e+00 | 1.31e-03 | Male-biased |
| PCDHB14 related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for PCDHB14 |
| RBPs related to ES in PCDHB14. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| PCDHB14 related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs4958187 | chr5:133831191:G:A | - | 0.150797238951021 | 0.0307163041917158 | PAAD | Female-baised eQTL |
| rs156055 | chr5:132164484:G:A | - | 0.156722942985426 | 0.0197598095720975 | KIRC | Female-baised eQTL |
| rs72789387 | chr5:132092854:G:A | - | 0.149683475337802 | 0.026721568985306 | KIRC | Female-baised eQTL |
| rs10477148 | chr5:141609675:G:A | - | -0.0496780082421495 | 0.0107526653946065 | LUAD | Female-baised eQTL |
| rs7712601 | chr5:141538221:T:C | - | -0.0491514932772968 | 0.0127321522393397 | LUAD | Female-baised eQTL |
| rs740474 | chr5:141545795:C:T | - | -0.0491514932772968 | 0.0127321522393397 | LUAD | Female-baised eQTL |
| rs6879677 | chr5:141575387:A:G | - | -0.0489733437595817 | 0.0133042386549785 | LUAD | Female-baised eQTL |
| rs2302103 | chr5:141576210:C:T | - | -0.0489733437595817 | 0.0133042386549785 | LUAD | Female-baised eQTL |
| rs1479585 | chr5:141596961:G:C | - | -0.0487569335385739 | 0.0140210219723289 | LUAD | Female-baised eQTL |
| rs6880745 | chr5:141601680:C:A | - | -0.0487569335385739 | 0.0140210219723289 | LUAD | Female-baised eQTL |
| rs2530223 | chr5:141634927:T:C | - | -0.0462561724502836 | 0.0339922204215425 | LUAD | Female-baised eQTL |
| rs4912761 | chr5:141501907:G:T | - | -0.0435568608083965 | 0.0363316991263224 | LUAD | Female-baised eQTL |
| rs2299023 | chr5:141501146:T:C | - | -0.0432966037805423 | 0.0397582086598796 | LUAD | Female-baised eQTL |
| rs2299024 | chr5:141501198:G:C | - | -0.0432966037805423 | 0.0397582086598796 | LUAD | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs4421089 | chr5:148649260:A:T | - | 0.15329746063352 | 0.00102470952487883 | COAD | Male-baised eQTL |
| rs35660841 | chr5:148649056:G:T | - | 0.139336677079976 | 0.00312524539543543 | COAD | Male-baised eQTL |
| rs79244112 | chr5:133796798:G:C | - | 0.102671912489313 | 0.00329147178061427 | COAD | Male-baised eQTL |
| rs79016519 | chr5:133796252:G:A | - | 0.0979436323695498 | 0.00370941029718134 | COAD | Male-baised eQTL |
| rs36103249 | chr5:148686798:T:C | - | 0.131331683465824 | 0.00496483203705187 | COAD | Male-baised eQTL |
| rs10065573 | chr5:149636948:T:C | - | 0.0817926596576923 | 0.00606750210331717 | COAD | Male-baised eQTL |
| rs17710737 | chr5:149638370:T:C | - | 0.0817926596576923 | 0.00606750210331717 | COAD | Male-baised eQTL |
| rs79291276 | chr5:149638512:A:T | - | 0.0817926596576923 | 0.00606750210331717 | COAD | Male-baised eQTL |
| rs73799452 | chr5:151132885:C:T | - | 0.0979885782302991 | 0.00790627195889738 | COAD | Male-baised eQTL |
| rs57517327 | chr5:149636706:G:C | - | 0.0782648477999514 | 0.00865301845940579 | COAD | Male-baised eQTL |
| rs3867422 | chr5:133796011:C:G | - | 0.0931411476639506 | 0.00929700237341866 | COAD | Male-baised eQTL |
| rs4489048 | chr5:149631240:C:T | - | 0.0779932176187214 | 0.00990734316105359 | COAD | Male-baised eQTL |
| rs34619946 | chr5:148679249:A:G | - | 0.120478066134541 | 0.0111515827322149 | COAD | Male-baised eQTL |
| rs13168015 | chr5:134504618:G:A | - | 0.0787257809821961 | 0.0123850283729679 | COAD | Male-baised eQTL |
| rs10041787 | chr5:138083805:G:T | - | 0.0814680859086353 | 0.0131002965172525 | COAD | Male-baised eQTL |
| rs7733751 | chr5:149597408:G:A | - | 0.0837354531286141 | 0.0138619299408053 | COAD | Male-baised eQTL |
| rs10069772 | chr5:132704996:A:G | - | -0.0770475918975261 | 0.0145175989654219 | COAD | Male-baised eQTL |
| rs9324676 | chr5:151133729:T:A | - | 0.0890842993810334 | 0.0149579231158536 | COAD | Male-baised eQTL |
| rs10065458 | chr5:149615616:G:A | - | 0.0754857092251646 | 0.0162628475505108 | COAD | Male-baised eQTL |
| rs10061018 | chr5:149613507:C:T | - | 0.0747057275770683 | 0.0166520695071903 | COAD | Male-baised eQTL |
| rs7704793 | chr5:144705798:A:T | - | 0.0533054394525171 | 0.0189129753495834 | COAD | Male-baised eQTL |
| rs11955881 | chr5:136071617:G:A | - | 0.11649023803718 | 0.0204146848583647 | COAD | Male-baised eQTL |
| rs10476742 | chr5:149625185:G:A | - | 0.0732386979720064 | 0.0204926442544301 | COAD | Male-baised eQTL |
| rs78820823 | chr5:149621720:T:C | - | 0.0731478935625726 | 0.0208973355930029 | COAD | Male-baised eQTL |
| rs2279132 | chr5:149634024:G:A | - | 0.0734049830900715 | 0.0221192299073355 | COAD | Male-baised eQTL |
| rs10073329 | chr5:149615792:T:C | - | 0.0718902184857077 | 0.0229649654111752 | COAD | Male-baised eQTL |
| rs62364637 | chr5:135745933:T:G | - | 0.0940127279872241 | 0.0235424657470779 | COAD | Male-baised eQTL |
| rs75464155 | chr5:149606462:T:A | - | 0.0793337865743582 | 0.0249584810086624 | COAD | Male-baised eQTL |
| rs57077174 | chr5:149607958:C:T | - | 0.0793337865743582 | 0.0249584810086624 | COAD | Male-baised eQTL |
| rs59112074 | chr5:135753335:C:T | - | 0.094229778435681 | 0.0251484171585476 | COAD | Male-baised eQTL |
| rs76492851 | chr5:133797920:C:T | - | 0.0916963657512899 | 0.0257367151076819 | COAD | Male-baised eQTL |
| rs55983857 | chr5:137931692:C:G | - | 0.0771037264318682 | 0.027042960494344 | COAD | Male-baised eQTL |
| rs10476741 | chr5:149624938:G:T | - | 0.0699933327080282 | 0.0283548144262817 | COAD | Male-baised eQTL |
| rs56215870 | chr5:137909606:G:A | - | 0.0686521330206438 | 0.0296927593507653 | COAD | Male-baised eQTL |
| rs1715354 | chr5:143973877:C:A | - | 0.121374640246288 | 0.0302162168097477 | COAD | Male-baised eQTL |
| rs28547951 | chr5:149621378:C:T | - | 0.0692551173454952 | 0.0304670164111124 | COAD | Male-baised eQTL |
| rs10038415 | chr5:137965178:T:C | - | 0.0665116767647868 | 0.0337191300458279 | COAD | Male-baised eQTL |
| rs374450556 | chr5:137972915:C:T | - | 0.0665116767647868 | 0.0337191300458279 | COAD | Male-baised eQTL |
| rs4621597 | chr5:133879021:T:A | - | 0.0874207504857308 | 0.0343059913301067 | COAD | Male-baised eQTL |
| rs188451001 | chr5:137970179:C:T | - | 0.0665180674976304 | 0.0345331288495111 | COAD | Male-baised eQTL |
| rs1820072 | chr5:148678145:A:T | - | 0.0474132716219493 | 0.034852475607505 | COAD | Male-baised eQTL |
| rs56123543 | chr5:133918062:C:A | - | 0.0469466138721216 | 0.0350718680816972 | COAD | Male-baised eQTL |
| rs79128426 | chr5:133795583:T:G | - | 0.0793335570592366 | 0.0356133214365194 | COAD | Male-baised eQTL |
| rs17683751 | chr5:133918158:A:G | - | 0.0466334066717091 | 0.0362889279807464 | COAD | Male-baised eQTL |
| rs3733662 | chr5:149628904:C:A | - | 0.0717132443650091 | 0.0373042873881017 | COAD | Male-baised eQTL |
| rs28705982 | chr5:151134286:G:A | - | 0.0831392053258933 | 0.0376350931956923 | COAD | Male-baised eQTL |
| rs17646132 | chr5:133795438:T:C | - | 0.0788702084020263 | 0.0376828424577035 | COAD | Male-baised eQTL |
| rs79450526 | chr5:137983213:A:C | - | 0.0653388953943569 | 0.0383459044837475 | COAD | Male-baised eQTL |
| rs72833398 | chr5:147551770:C:A | - | 0.0640537956448492 | 0.0398424250969963 | COAD | Male-baised eQTL |
| rs12658188 | chr5:143628720:T:C | - | 0.102852792122499 | 0.0425321358485692 | COAD | Male-baised eQTL |
| rs56754897 | chr5:137943737:T:A | - | 0.0642267884701945 | 0.0438464407987691 | COAD | Male-baised eQTL |
| rs13359605 | chr5:137944232:G:A | - | 0.0642267884701945 | 0.0438464407987691 | COAD | Male-baised eQTL |
| rs4557401 | chr5:137948123:T:C | - | 0.0642267884701945 | 0.0438464407987691 | COAD | Male-baised eQTL |
| rs72801646 | chr5:137949660:C:T | - | 0.0642267884701945 | 0.0438464407987691 | COAD | Male-baised eQTL |
| rs10036824 | chr5:137962975:T:C | - | 0.0642267884701945 | 0.0438464407987691 | COAD | Male-baised eQTL |
| rs11242400 | chr5:137963658:G:A | - | 0.0642267884701945 | 0.0438464407987691 | COAD | Male-baised eQTL |
| rs56316096 | chr5:137978377:A:G | - | 0.0642267884701945 | 0.0438464407987691 | COAD | Male-baised eQTL |
| rs17523263 | chr5:137978780:T:C | - | 0.0642267884701945 | 0.0438464407987691 | COAD | Male-baised eQTL |
| rs7737549 | chr5:137984963:G:A | - | 0.0642267884701945 | 0.0438464407987691 | COAD | Male-baised eQTL |
| rs11242406 | chr5:137996329:C:T | - | 0.0642267884701945 | 0.0438464407987691 | COAD | Male-baised eQTL |
| rs72801648 | chr5:137996636:A:G | - | 0.0642267884701945 | 0.0438464407987691 | COAD | Male-baised eQTL |
| rs1564103 | chr5:138004529:C:A | - | 0.0642267884701945 | 0.0438464407987691 | COAD | Male-baised eQTL |
| rs1564104 | chr5:138004608:G:A | - | 0.0642267884701945 | 0.0438464407987691 | COAD | Male-baised eQTL |
| rs4277911 | chr5:138004754:C:T | - | 0.0642267884701945 | 0.0438464407987691 | COAD | Male-baised eQTL |
| rs28587093 | chr5:138008498:C:A | - | 0.0642267884701945 | 0.0438464407987691 | COAD | Male-baised eQTL |
| rs113175618 | chr5:143627816:G:A | - | 0.10244313977772 | 0.0438983780186389 | COAD | Male-baised eQTL |
| rs6861962 | chr5:143370736:A:C | - | -0.103172306827595 | 0.0456654665492363 | COAD | Male-baised eQTL |
| rs67599220 | chr5:147550822:C:T | - | 0.0621190228089489 | 0.0491434149973732 | COAD | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of PCDHB14 |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
